Related Experiment Videos

Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children

Zhengxiu Luo1, Jian Luo, Enmei Liu

  • 1Department of Respiratory, Children's Hospital, Chong Qing Medical University, Chongqing, China.

Pediatric Pulmonology
|February 13, 2013
PubMed
Abstract

Insights

Adding prednisolone to azithromycin significantly improves outcomes for children with refractory Mycoplasma pneumonia pneumonia (MPP). This combination therapy accelerates fever reduction and symptom resolution compared to azithromycin alone.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Pharmacology

Background:

  • Mycoplasma pneumonia pneumonia (MPP) can be refractory to standard antibiotic treatment in children.
  • Limited treatment options exist for severe or persistent pediatric MPP cases.

Purpose of the Study:

  • To prospectively evaluate the efficacy of adding prednisolone to azithromycin for treating refractory pediatric MPP.
  • To compare treatment outcomes between children receiving azithromycin plus prednisolone and those receiving azithromycin alone.

Main Methods:

  • A prospective study involving 58 children with refractory MPP.
  • Participants were randomized to receive either azithromycin with prednisolone (treatment group, n=28) or azithromycin alone (control group, n=30).
  • Clinical parameters (temperature, respiratory symptoms) and radiological findings (infiltrate absorption, atelectasis, effusion) were monitored, along with serum ferritin and LDH levels.

Main Results:

  • The azithromycin-prednisolone group showed significantly faster defervescence (8-48 hours) compared to the control group.
  • Shorter durations of hypoxemia and dyspnea were observed in the treatment group (P < 0.05).
  • Improved radiological resolution rates (infiltrate absorption, atelectasis, pleural effusion) and lower serum ferritin/LDH levels were noted in the treatment group (P < 0.05).

Conclusions:

  • Combination therapy with azithromycin and prednisolone is more effective than azithromycin alone for refractory pediatric MPP.
  • Prednisolone may help reduce inflammation and improve clinical outcomes in severe MPP cases.
  • This treatment strategy offers a promising approach for managing difficult-to-treat pediatric pneumonia.
Keywords:
azithromycinchildrenprednisolonerefractory mycoplasma pneumoniae pneumonia

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: